Menu
Recruiting NCT07348081

Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department.

No phase Interventional Frailty Syndrome Caregiver Burden for Those Who Care for Adults With Impaired Functional Status

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Caregivers supporting vulnerable patients and using the MyMonka solution..
Who it may be relevant to
Registry conditions: Frailty Syndrome, Caregiver Burden for Those Who Care for Adults With Impaired Functional Status. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The RW-HOMECARE study is a prospective, longitudinal, real-world pilot trial designed to assess the impact of proposing the Monka digital solution to non-professional caregivers of patients discharged from emergency or short-stay units. The primary objective is to measure changes in caregiver burden using the ZBI-12 scale at baseline, 30 days, and 90 days. Secondary objectives include evaluating caregivers' physical and mental quality of life (SF-12), patient frailty (Clinical Frailty Scale), and the incidence of adverse events such as emergency visits, unplanned hospitalizations, falls, institutionalization, and death within 90 days. The study also examines the usability, acceptability, and satisfaction with Monka digital solution through standardized questionnaires, the correlation between algorithm-generated vulnerability scores and established measures, and reasons for non-adoption. Eligible dyads (patient and caregiver) are recruited at discharge from emergency or short-stay units. After informed consent, caregivers receive free access to Monka digital solution for 3 months, along with a user guide. Follow-up assessments are conducted by phone at Day 30 and Day 90 (±14 days). All interventions by the coordinating nurse are tracked and analyzed quantitatively and qualitatively.

Interventions

  • Other Caregivers supporting vulnerable patients and using the MyMonka solution.
    Testing of the MyMonka solution; Response to questionnaires during the follow-up period on quality of life and burden measurement

Primary outcome measures

  • Change in the score on the 12-item Zarit Burden Interview questionnaire (ZBI-12, Appendix 1), measured on days 0, 30, and 90, among family caregivers participating in the study. [Time frame: Days 0, 30 and 90]
Secondary outcome measures (4)
  • Change in the physical and mental quality of life of caregivers, expressed as the difference between SF-12 questionnaire scores at baseline, on day 30, and on day 90. [Time frame: Days 30 and 90]
  • Change in patient frailty expressed as the difference between the Clinical Frailty Scale score obtained at inclusion and on day 90. [Time frame: Days 0 and 90]
  • Percentage of people affected by the following adverse events within three months of returning home: new emergency room visits, unscheduled hospitalizations and their duration, falls, home hospitalizations, institutionalization, and death. [Time frame: Days 90]
  • Evaluation of the use, acceptability, usability, and impact of the Monka digital solution for caregivers through intervention tracking, algorithm-based vulnerability assessment, and standardized questionnaires over a 90-day period. [Time frame: Days 0 and 90]

Eligibility criteria

Inclusion criteria

FOR THE PATIENT

  • Person aged 18 or over, treated in the Emergency Department or Emergency Beds
  • Affiliated with Social Security
  • Having an adult non-professional relative helping them with one or more activities of daily living
  • Having a medical decision to return home within the next 72 hours
  • Who has given their free, informed, and express consent FOR THE CAREGIVER
  • Individuals aged 18 or older
  • Who are non-professional caregivers as defined in Article L. 113-1-3 of the Social Action and Families Code, living with or separately from the person being cared for (20)
  • Providing assistance to the patient with one or more activities of daily living, i.e., shopping, medical appointments, coordination of care, administrative tasks, and moral support
  • Access to a cell phone, computer, or tablet with an internet connection
  • Having given their free, informed, and express consent

Exclusion criteria

FOR THE PATIENT

  • Non-French speakers
  • People living in a medical institution or scheduled for institutionalization within the next 3 months
  • People receiving home hospitalization (HAD) or palliative care at home
  • People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle) FOR THE CAREGIVER
  • Non-French speakers
  • People with cognitive or psychiatric disorders that prevent them from understanding and using the MONKA solution
  • People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • Hôpital Paris Saint-Joseph — Paris

Identifiers

NCT: NCT07348081 · 782_RW-HOMECARE · ID RCB : 2025-A02182-47

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗